What Position Did Arthritis Foundation and American College of Rheumatology Take Following FDA Action on NSAIDs?
What Position Did Arthritis Foundation and American College of Rheumatology Take Following FDA Action on NSAIDs? Friday June 3, 2005 Arthritis patients were left confused following the FDA action in April 2005 to withdraw Bextra from the market and add warnings and labeling changes to other NSAIDs. Many patients were left wondering if the drugs they had been taking to treat arthritis pain and inflammation were safe or if they needed to switch to another medication. What did the American College of Rheumatology and Arthritis Foundation think about the FDA action? • Information For Patients Regarding COX-2 Selective NSAIDs (from ACR) • Letter to FDA Regarding NSAIDs (from ACR) •
Related Questions
- Are these DHHS recommendations different from the earlier recommendations of the American Heart Association (AHA) and the American College of Cardiology (ACC)?
- What Position Did Arthritis Foundation and American College of Rheumatology Take Following FDA Action on NSAIDs?
- What is the American College of Rheumatology Conference?
